Cover Image
市場調查報告書

經導管二尖瓣:醫療設備的開發平台分析

Transcatheter Mitral Valves (TMVI) - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 579815
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
Back to Top
經導管二尖瓣:醫療設備的開發平台分析 Transcatheter Mitral Valves (TMVI) - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年11月07日 內容資訊: 英文 90 Pages
簡介

本報告提供經導管二尖瓣的開發中產品的相關調查,提供產品開發·臨床實驗的整體進展,及企業·各產品詳細趨勢(臨床實驗的進展,開始/結束時期,核准預測等),總括性彙整近幾年的開發·資本交易趨勢等資訊。

第1章 目錄

第2章 簡介

  • 經導管二尖瓣概要

第3章 經導管二尖瓣-開發中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各核准機關
  • 開發中產品:各預定核准時期
  • 現在進行中的臨床實驗

第4章 經導管二尖瓣-正在開發的開發中產品:各企業

  • 經導管二尖瓣企業:各開發階段的開發中產品
  • 經導管二尖瓣:各開發階段的開發中產品

第5章 經導管二尖瓣:企業及產品概要

  • 4C Medical Technologies Inc
    • 開發中產品及進行中的臨床實驗概要
  • Annulon
  • Celyad SA
  • Cephea Valve Technologies, Inc.
  • Daidalos Solutions BV
  • Direct Flow Medical Inc
  • Edwards Lifesciences Corp
  • Emory University
  • HighLife SAS
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc
  • Sino Medical Sciences Technology Inc
  • Trinity College Dublin
  • University College London
  • Valtech Cardio Ltd
  • Venus MedTech

第6章 經導管二尖瓣:近幾年趨勢

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 聯絡處
  • 免責聲明

圖表清單

目錄
Product Code: GDME0496EPD

GlobalData's Medical Devices sector report, "Transcatheter Mitral Valves (TMVI) - Medical Devices Pipeline Assessment, 2017" provides an overview of Transcatheter Mitral Valves (TMVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Mitral Valves (TMVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Mitral Valves (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valves (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valves (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Transcatheter Mitral Valves (TMVI) Overview 7

3 Products under Development 8

  • 3.1 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development 8
  • 3.2 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Territory 9
  • 3.3 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Regulatory Path 10
  • 3.4 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Estimated Approval Date 11
  • 3.5 Transcatheter Mitral Valves (TMVI) - Ongoing Clinical Trials 12

4 Transcatheter Mitral Valves (TMVI) - Pipeline Products under Development by Companies 13

  • 4.1 Transcatheter Mitral Valves (TMVI) Companies - Pipeline Products by Stage of Development 13
  • 4.2 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development 14

5 Transcatheter Mitral Valves (TMVI) Companies and Product Overview 15

  • 5.1 4C Medical Technologies Inc Company Overview 15
    • 5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Annulon Company Overview 16
    • 5.2.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Celyad SA Company Overview 17
    • 5.3.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Cephea Valve Technologies, Inc. Company Overview 18
    • 5.4.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Daidalos Solutions BV Company Overview 19
    • 5.5.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 Direct Flow Medical Inc Company Overview 20
    • 5.6.1 Direct Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.7 Edwards Lifesciences Corp Company Overview 21
    • 5.7.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.8 Emory University Company Overview 30
    • 5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.9 HighLife SAS Company Overview 31
    • 5.9.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.10 LivaNova PLC Company Overview 34
    • 5.10.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.11 Medtronic plc Company Overview 37
    • 5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.12 Micro Interventional Devices, Inc. Company Overview 42
    • 5.12.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.13 Mitralix Ltd. Company Overview 43
    • 5.13.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.14 MitrAssist Ltd. Company Overview 44
    • 5.14.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.15 MValve Technologies Ltd. Company Overview 45
    • 5.15.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.16 NaviGate Cardiac Structures, Inc. Company Overview 48
    • 5.16.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.17 Neovasc Inc Company Overview 51
    • 5.17.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.18 Sino Medical Sciences Technology Inc Company Overview 54
    • 5.18.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.19 Trinity College Dublin Company Overview 55
    • 5.19.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.20 University College London Company Overview 56
    • 5.20.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.21 Valtech Cardio Ltd Company Overview 57
    • 5.21.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.22 Venus MedTech Company Overview 58
    • 5.22.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 58

6 Transcatheter Mitral Valves (TMVI)- Recent Developments 59

  • 6.1 Oct 24, 2017: 4C Medicals Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition 59
  • 6.2 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 59
  • 6.3 Oct 23, 2017: First Patient Treated in Landmark Transcatheter Mitral Valve Replacement Pivotal Trial 61
  • 6.4 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 62
  • 6.5 Sep 12, 2017: Neovasc Provides Tiara Clinical Update 63
  • 6.6 Sep 01, 2017: Decision from Appeals Court upholds lower court decisions but denies injunction 64
  • 6.7 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 64
  • 6.8 Aug 03, 2017: 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit 67
  • 6.9 Jun 16, 2017: Neovasc Announces German Court Ruling 67
  • 6.10 Jun 15, 2017: Neovasc Tiara Featured in TVT 2017 Presentation 68
  • 6.11 Jun 15, 2017: 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum 68
  • 6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 69
  • 6.13 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 72
  • 6.14 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 73
  • 6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 76
  • 6.16 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 77
  • 6.17 Jan 19, 2017: LHSC First in Ontario to Implant Canadian made Mitral Valve Device 78
  • 6.18 Dec 23, 2016: Neovasc Announces Update in Litigation with CardiAQ 79
  • 6.19 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 79
  • 6.20 Dec 06, 2016: Neovasc Provides Update On Its Tiara Mitral Valve Clinical Program 81
  • 6.21 Nov 28, 2016: Neovasc Receives Regulatory Approval To Initiate TIARA II CE Mark Study 82
  • 6.22 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 83
  • 6.23 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 85
  • 6.24 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 86

7 Appendix 87

  • 7.1 Methodology 87
  • 7.2 About GlobalData 90
  • 7.3 Contact Us 90
  • 7.4 Disclaimer 90

List of Tables

  • Table 1: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development 8
  • Table 2: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Territory 9
  • Table 3: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Regulatory Path 10
  • Table 4: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Estimated Approval Date 11
  • Table 5: Transcatheter Mitral Valves (TMVI) - Ongoing Clinical Trials 12
  • Table 6: Transcatheter Mitral Valves (TMVI) Companies - Pipeline Products by Stage of Development 13
  • Table 7: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development 14
  • Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 9: TMVR Implant - Product Status 15
  • Table 10: TMVR Implant - Product Description 15
  • Table 11: Annulon Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 12: Mitral Valve Replacement Device - Product Status 16
  • Table 13: Mitral Valve Replacement Device - Product Description 16
  • Table 14: Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 15: Mitral Valve Neo-chordae - Product Status 17
  • Table 16: Mitral Valve Neo-chordae - Product Description 17
  • Table 17: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 18: Mitral Valve Replacement Device - Product Status 18
  • Table 19: Mitral Valve Replacement Device - Product Description 18
  • Table 20: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 21: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status 19
  • Table 22: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description 19
  • Table 23: Direct Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 24: Direct Flow Medical Transcatheter Mitral Valve - Product Status 20
  • Table 25: Direct Flow Medical Transcatheter Mitral Valve - Product Description 20
  • Table 26: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 27: Cardiaq Mitral Valve - Product Status 21
  • Table 28: Cardiaq Mitral Valve - Product Description 22
  • Table 29: FORTIS Mitral Transcatheter Heart Valve - Product Status 22
  • Table 30: FORTIS Mitral Transcatheter Heart Valve - Product Description 22
  • Table 31: PASCAL Transcatheter Mitral Valve Repair System - Product Status 23
  • Table 32: PASCAL Transcatheter Mitral Valve Repair System - Product Description 23
  • Table 33: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Status 23
  • Table 34: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Description 24
  • Table 35: Second Generation Transapical Transcatheter Mitral Valve - Product Status 24
  • Table 36: Second Generation Transapical Transcatheter Mitral Valve - Product Description 24
  • Table 37: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview 25
  • Table 38: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems) For the Treatment of Moderate to Severe Mitral Regurgitation 26
  • Table 39: Cardiaq Mitral Valve - Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems) For the Treatment of Moderate to Severe Mitral Regurgitation 27
  • Table 40: Cardiaq Mitral Valve - Reduction or elimination of Mitral Regurgitation in Degenerative or Functional Mitral Regurgitation with the CardiAQ-Edwards Transcatheter Mitral Valve: The RELIEF Trial 27
  • Table 41: Sapien 3 Heart Valve - Mitral Annular Calcification - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study 28
  • Table 42: Sapien 3 Heart Valve - Mitral Annular Calcification - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with NovaFlex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery. 28
  • Table 43: PASCAL Transcatheter Mitral Valve Repair System - CE Mark Study of PASCAL Transcatheter Mitral Valve Repair System 29
  • Table 44: PASCAL Transcatheter Mitral Valve Repair System - The CLASP Study Edwards PASCAL TranScatheter Mitral Valve Repair System Study 29
  • Table 45: Emory University Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 46: MitraCath - Product Status 30
  • Table 47: MitraCath - Product Description 30
  • Table 48: HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 49: Transcatheter Mitral Valve Replacement System - Product Status 31
  • Table 50: Transcatheter Mitral Valve Replacement System - Product Description 31
  • Table 51: HighLife SAS - Ongoing Clinical Trials Overview 32
  • Table 52: Transcatheter Mitral Valve Replacement System - HighLife Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk 33
  • Table 53: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 54: Caisson TMVR System - Product Status 34
  • Table 55: Caisson TMVR System - Product Description 34
  • Table 56: LivaNova PLC - Ongoing Clinical Trials Overview 35
  • Table 57: Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE) 36
  • Table 58: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 59: Intrepid Transcatheter Mitral Valve Replacement - Product Status 37
  • Table 60: Intrepid Transcatheter Mitral Valve Replacement - Product Description 37
  • Table 61: TCV - Mitral - Product Status 38
  • Table 62: TCV - Mitral - Product Description 38
  • Table 63: Twelve Transcatheter Mitral Valve Replacement System - Product Status 38
  • Table 64: Twelve Transcatheter Mitral Valve Replacement System - Product Description 38
  • Table 65: Medtronic plc - Ongoing Clinical Trials Overview 39
  • Table 66: Twelve Transcatheter Mitral Valve Replacement System - Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation 40
  • Table 67: Intrepid Transcatheter Mitral Valve Replacement - Evaluation of Safety and Efficacy of the Intrepid TMVR System in Patients with Severe, Symptomatic Mitral Valve Regurgitation: APOLLO Trial 41
  • Table 68: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 69: Endovalve - Product Status 42
  • Table 70: Endovalve - Product Description 42
  • Table 71: Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 72: MAESTRO - Product Status 43
  • Table 73: MAESTRO - Product Description 43
  • Table 74: MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 75: MitrAssist Valve - Product Status 44
  • Table 76: MitrAssist Valve - Product Description 44
  • Table 77: MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 78: MValve Docking System - Product Status 45
  • Table 79: MValve Docking System - Product Description 45
  • Table 80: MValve Technologies Ltd. - Ongoing Clinical Trials Overview 46
  • Table 81: MValve Docking System - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 47
  • Table 82: NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 83: Navi Mitral Valved Stent - Product Status 48
  • Table 84: Navi Mitral Valved Stent - Product Description 48
  • Table 85: NaviGate Cardiac Structures, Inc. - Ongoing Clinical Trials Overview 49
  • Table 86: Navi Mitral Valved Stent - Navi Valved Stent for Correction of Severe Functional Mitral Regurgitation (FMR) 50
  • Table 87: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 88: Tiara Transcatheter Mitral Valve - Product Status 51
  • Table 89: Tiara Transcatheter Mitral Valve - Product Description 51
  • Table 90: Neovasc Inc - Ongoing Clinical Trials Overview 52
  • Table 91: Tiara Transcatheter Mitral Valve - Early Feasibility Study of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System 53
  • Table 92: Tiara Transcatheter Mitral Valve - Tiara Transcatheter Mitral Valve Replacement Study: TIARA-II 53
  • Table 93: Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 94: AccuFit Transapical Mitral Valve Replacement Device - Product Status 54
  • Table 95: AccuFit Transapical Mitral Valve Replacement Device - Product Description 54
  • Table 96: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 97: MiVaR Device - Product Status 55
  • Table 98: MiVaR Device - Product Description 55
  • Table 99: University College London Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 100: Percutaneous Mitral Valve Device - Product Status 56
  • Table 101: Percutaneous Mitral Valve Device - Product Description 56
  • Table 102: Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 103: Valtech Cardiovalve - Product Status 57
  • Table 104: Valtech Cardiovalve - Product Description 57
  • Table 105: Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 106: Tresillo System - Product Status 58
  • Table 107: Tresillo System - Product Description 58
  • Table 108: Glossary 89

List of Figures

  • Figure 1: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development 8
  • Figure 2: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Territory 9
  • Figure 3: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Regulatory Path 10
  • Figure 4: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Estimated Approval Date 11
  • Figure 5: Transcatheter Mitral Valves (TMVI) - Ongoing Clinical Trials 12
Back to Top